Transgene Biotek Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
-
1
1
1
1
Total Accounts Receivable
186
184
165
18
2
Inventories
13
11
10
10
6
Other Current Assets
7
7
7
7
-
Total Current Assets
207
202
183
35
8
Net Property, Plant & Equipment
984
61
54
37
34
Total Investments and Advances
-
8
8
-
-
Intangible Assets
1,564
3,312
3,192
3,049
1,930
Other Assets
930
-
-
9
9
Total Assets
3,686
3,583
3,438
3,130
1,981
ST Debt & Current Portion LT Debt
165
71
82
89
96
Accounts Payable
171
171
156
8
5
Other Current Liabilities
14
14
15
15
16
Total Current Liabilities
351
256
252
113
117
Long-Term Debt
59
59
63
63
64
Provision for Risks & Charges
57
1,209
1,209
1,209
1,153
Other Liabilities
-
-
-
-
56
Total Liabilities
467
1,524
1,524
1,385
1,390
Common Equity (Total)
3,219
2,060
1,914
1,744
590
Total Shareholders' Equity
3,219
2,060
1,914
1,744
590
Total Equity
3,219
2,060
1,914
1,744
590
Liabilities & Shareholders' Equity
3,686
3,583
3,438
3,130
1,981

About Transgene Biotek

View Profile
Address
Plot Nos. 68, 69 & 70
Hyderabad TS 502325
India
Employees -
Website http://www.transgenebiotek.com
Updated 09/14/2018
Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. Its activities include research and development of vaccines. The company operates through the following business segments: Diagnostic Services, and CRO Services.